![\"\"](\"https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/diagnostic-covid-scaled.jpg\" "\\"\\"")
<\/p>\n
Scopul evalu\u0103rii multidisciplinare este de a demonstra c\u0103 alte afec\u021biuni tratabile nu au fost omise \u00een timpul confirm\u0103rii unui diagnostic de SPC.<\/p>\n
Care sunt testele de evaluare pentru sindromul post-COVID?<\/h2>\n
De\u0219i nu exist\u0103 un set standard de teste care s\u0103 poat\u0103 confirma definitiv SPC, anumite investiga\u021bii pot oferii indica\u021bii utile [4]. Analizele de s\u00e2nge precum hemoleucograma complet\u0103, markeri inflamatori precum PCR \u0219i VSH, \u0219i m\u0103sur\u0103tori ale D-dimerilor \u0219i feritinei eviden\u021biaz\u0103 prezen\u021ba inflama\u021biei \u00een corp, respectiv probleme de coagulare \u0219i nivelul de fier [5].<\/p>\n
Alte teste recomandate pentru diagnosticarea SPC sunt testele func\u021biei tiroidiene, nivelele de vitamine B12 \u0219i D [6]. \u00cen cazul pacien\u021bilor cu simptome cardiace, pot fi recomandate electrocardiograme, ecocardiograme \u0219i teste ale biomarkerilor cardiaci precum troponina [7].<\/p>\n
Afec\u021biunile respiratorii pot necesita testarea func\u021biei pulmonare sau imagistica, cum ar fi radiografiile toracice sau tomografia computerizat\u0103 [8]. Simptomele neurologice pot fi investigate prin scan\u0103ri RMN \u0219i evalu\u0103ri neurocognitive [9].<\/p>\n
Dac\u0103 se suspecteaz\u0103 sindromul de tahicardie postural\u0103 ortostatic\u0103, testarea autonom\u0103* poate ajuta la confirmarea diagnosticului \u0219i la evaluarea gradului de disfunc\u021bie a sistemului nervos autonom (*testul cu mas\u0103 \u00eenclinat\u0103, pentru observarea ritmului cardiac \u0219i a tensiunii arteriale la modific\u0103rile pozi\u021bionale) [10].<\/p>\n
- \n
- Analize de s\u00e2nge (Hemoleucogram\u0103, PCR, VSH, D-dimer, feritin\u0103, vitaminele B12 \u0219i D);<\/li>\n
- Teste ale func\u021biei tiroidiene;<\/li>\n
- Evalu\u0103ri cardiace (ECG, ecocardiogram\u0103, nivelul de troponin\u0103);<\/li>\n
- Teste ale func\u021biei pulmonare;<\/li>\n
- Evalu\u0103ri neurologice \u0219i neurocognitive (RMN, tomografie computerizat\u0103);<\/li>\n
- Teste autonome (dac\u0103 se suspecteaz\u0103 sindromul de tahicardie postural\u0103 ortostatic\u0103);<\/li>\n<\/ul>\n
![\"\"](\"https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/evaluare-post-covid-scaled.jpg\" "\\"\\"")
<\/p>\nToate aceste teste \u0219i investiga\u021bii ajut\u0103 la excluderea leziunilor structurale, detectarea complica\u021biilor \u0219i oferirea unei imagini mai clare a st\u0103rii de s\u0103n\u0103tate a pacientului.<\/p>\n
Terapii de recuperare pentru sindromul Post-COVID<\/h2>\n
Tratamentul SPC trebuie ales \u00een func\u021bie de simptome. Astfel, \u00een cazul oboselii cronice, pacien\u021bii sunt \u00eencuraja\u021bi s\u0103 utilizeze strategii de stimulare cardiac\u0103 \u0219i s\u0103 evite suprasolicitarea, o tehnic\u0103 utilizat\u0103 frecvent \u00een gestionarea sindroamelor de oboseal\u0103 cronic\u0103 [11,12].<\/p>\n
Kinetoterapia poate ajuta la restabilirea for\u021bei musculare \u0219i a rezisten\u021bei, \u00een timp ce terapia ocupa\u021bional\u0103 poate ajuta la adaptarea sarcinilor zilnice [13]. Dietoterapia e recomandat\u0103 \u00een cazurile de tulbur\u0103ri gastrointestinale \u0219i deficien\u021be nutri\u021bionale [14].<\/p>\n
Durerea \u0219i inflama\u021bia pot fi tratate cu medicamente analgezice \u0219i antiinflamatoare [15]. Simptomele respiratorii sunt adesea abordate cu inhalatoare, exerci\u021bii de respira\u021bie sau reabilitare pulmonar\u0103 [16].<\/p>\n
Problemele cognitive, cum ar fi cea\u021ba mintal\u0103, se pot ameliora prin neuroreabilitare, medica\u021bie \u0219i odihn\u0103 adecvat\u0103 [17]. Simptomele psihologice, cum ar fi anxietatea sau depresia, ar trebui gestionate activ prin terapie cognitiv\u0103, consiliere, \u0219i grupuri de sprijin [18].<\/p>\n
![\"\"](\"https:\/\/roneuro.ro\/blog\/wp-content\/uploads\/2025\/09\/tabel-burnout-scaled.jpg\" "\\"\\"")
<\/p>\nEste important de men\u021bionat c\u0103 monitorizarea \u0219i tratarea comorbidit\u0103\u021bilor este esen\u021bial\u0103, deoarece SPC evolueaz\u0103 \u0219i pot fi necesare ajust\u0103ri ale planului de tratament. Toate aceste terapii ar trebui introduse treptat, adaptate la toleran\u021bele individuale \u0219i concentrate pe \u00eembun\u0103t\u0103\u021birea durabil\u0103 \u00een timp [19].<\/p><\/blockquote>\n
Resurse \u0219i suport pentru pacien\u021bi<\/h2>\n
Dac\u0103 ave\u021bi una sau mai multe din simptomele enumerate \u0219i b\u0103nui\u021bi c\u0103 ar putea fi vorba de sindrom Post-COVID, programa\u021bi-v\u0103 acum la o consulta\u021bie\u00a0<\/span>contact\u00e2nd recep\u021bia Institutului RoNeuro<\/strong> la num\u0103rul de telefon<\/span> 0374 46 2222<\/a><\/b>, luni \u0219i mar\u021bi \u00eentre orele 08:00 – 19:00<\/strong>, iar de miercuri p\u00e2n\u0103 vineri \u00eentre orele 08:00 – 18:00<\/strong>.\u00a0<\/span><\/p>\n
La momentul program\u0103rii, pute\u021bi opta \u0219i pentru consulta\u021bie neurologic\u0103 gratuit\u0103, decontat\u0103 prin Casa Na\u021bional\u0103 de Asigur\u0103ri de S\u0103n\u0103tate.\u00a0<\/span><\/p>\n
Program\u0103ri online neurologie<\/a><\/p>\n
Locui\u021bi \u00eentr-o zon\u0103 izolat\u0103 sau nu v\u0103 pute\u021bi deplasa la clinic\u0103? Institutul RoNeuro ofer\u0103 \u0219i op\u021biunea de <\/span>telemedicin\u0103<\/a>.<\/p>\n
Modific\u0103ri ale stilului de via\u021b\u0103 \u00een contextul sindromului post-COVID<\/h2>\n
Modific\u0103rile stilului de via\u021b\u0103 sunt esen\u021biale \u00een gestionarea SPC. Astfel, este necesar\u0103 revenirea \u00een mod gradat la activitatea fizic\u0103, utiliz\u00e2nd strategii de ritm pentru a evita acutizarea simptomelor [20].<\/p>\n
O diet\u0103 echilibrat\u0103, cu efect antiinflamator, bogat\u0103 \u00een fructe, legume, proteine slabe \u0219i gr\u0103simi s\u0103n\u0103toase, poate echilibra reac\u021bia sistemului imunitar, amelior\u00e2nd semnificativ tulbur\u0103rile gastrointestinale \u0219i deficien\u021bele nutri\u021bionale [21].<\/p>\n
Realizarea unei durate de somn nocturn de 8 ore, evit\u00e2nd pe c\u00e2t posibil \u00eentreruperile, \u0219i stresul prin tehnici precum medita\u021bia, yoga, exerci\u021bii de respira\u021bie [22].<\/p>\n
Asigurarea unui echilibru hidroelectrolitic adecvat pot ajuta, \u00een special \u00een cazurile de ame\u021beli sau intoleran\u021b\u0103 ortostatic\u0103 [23].<\/p>\n
- \n
- Revenire treptat\u0103 la activitate (\u201e\u00eencepe\u021bi cu pu\u021bin \u0219i merge\u021bi \u00eencet\u201d);<\/li>\n
- Diet\u0103 s\u0103n\u0103toas\u0103 cu efect antiinflamator;<\/li>\n
- Somn nocturn de 8 ore;<\/li>\n
- Reducerea stresului (mindfulness, yoga, exerci\u021bii de respira\u021bie);<\/li>\n
- Echilibru hidroelectrolitic (evitarea deshidrat\u0103rii \u0219i a v\u0103rs\u0103turilor).<\/li>\n<\/ul>\n
Aceste ajust\u0103ri holistice \u00eembun\u0103t\u0103\u021besc adesea calitatea vie\u021bii \u0219i ajut\u0103 la recuperarea pe termen lung reduc\u00e2nd totodat\u0103 povara fiziologic\u0103 a bolilor cronice.<\/p>\n
Cercet\u0103ri actuale despre sindromul Post-COVID \u0219i perspective viitoare<\/h2>\n
Cercetarea SPC se extinde rapid, iar ini\u021biative majore, precum proiectul NIH RECOVER, \u00ee\u0219i propun s\u0103 descopere mecanismele biologice ale SPC pentru a pune bazele unor tratamente c\u00e2t mai eficiente [24].<\/p>\n
Oamenii de \u0219tiin\u021b\u0103 investigheaz\u0103 r\u0103spunsul imunologic \u00een SPC, persisten\u021ba virusului, autoimunitatea \u0219i modific\u0103rile microbiomului. Studiile clinice exploreaz\u0103 eficacitatea terapiilor antivirale, a anticorpilor monoclonali, imunomodulatorilor \u0219i a protocoalelor de reabilitare [25,26].<\/p>\n
Se studiaz\u0103 \u0219i impactul vaccin\u0103rii anti COVID-19 \u00een vederea reducerii riscului \u0219i severit\u0103\u021bii SPC [27]. Dezvoltarea biomarkerilor de diagnostic [28] \u0219i a instrumentelor digitale pentru urm\u0103rirea simptomelor (bazate pe inteligen\u021b\u0103 artificial\u0103 [29]) poate \u00eembun\u0103t\u0103\u021bi diagnosticul \u0219i tratamentul \u00een viitor.<\/p>\n
- \n
- Mecanismele COVID-ului lung (Ini\u021biativa NIH RECOVER);<\/li>\n
- Disfunc\u021bia imun\u0103 \u0219i autoimunitatea;<\/li>\n
- Terapii de v\u00e2rf (imunomodulatori, anticorpi monoclonali);<\/li>\n
- Vaccinarea anti COVID-19;<\/li>\n
- Dezvoltarea de biomarkeri pentru diagnostic;<\/li>\n
- Instrumente emergente de urm\u0103rire \u0219i gestionare a simptomelor.<\/li>\n<\/ul>\n
Pe m\u0103sur\u0103 ce \u00een\u021belegerea noastr\u0103 se aprofundeaz\u0103, exist\u0103 speran\u021b\u0103 pentru terapii mai \u021bintite \u0219i strategii preventive.<\/p>\n
Concluzii<\/h2>\n
SPC reprezint\u0103 o afec\u021biune complex\u0103 evolutiv\u0103, care necesit\u0103 modele \u00eembun\u0103t\u0103\u021bite de recuperare \u0219i reabilitare centrate pe pacient.<\/p>\n
SPC necesit\u0103 o abordare nuan\u021bat\u0103, multidisciplinar\u0103 a diagnosticului \u0219i tratamentului. \u00cengrijirea personalizat\u0103, \u0219i cercetarea continu\u0103, ofer\u0103 cea mai bun\u0103 speran\u021b\u0103 de recuperare.<\/p>\n
Este important ca planul de tratament s\u0103 \u00eenceap\u0103 c\u00e2t mai cur\u00e2nd posibil, deoarece promptitudinea interven\u021biei medicale interdisciplinare poate avea un impact semnificativ asupra rezultatelor pe termen lung, evit\u00e2ndu-se episoadele de exacerbare a simptomelor SPC.<\/p>\n
Referin\u021be<\/h2>\n
- \n
- Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol. 2021 Jun 1;72(11):384-396. English, Spanish. doi: 10.33588\/rn.7211.2021230. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/34042167\/<\/a><\/li>\n
- Emiroglu C, Dicle M, Ozagar SD, Gorpelioglu S, Aypak C. Evaluation of post-acute-COVID-19, and long-COVID symptoms with a questionnaire: Within one year, a longitudinal study. North Clin Istanb. 2024 Apr 22;11(2):105-114. doi: 10.14744\/nci.2023.58908. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/38757107\/<\/a><\/li>\n
- Squillace N, Cogliandro V, Rossi E, Bellelli G, Pozzi M, Luppi F, Lettino M, Strepparava MG, Ferrarese C, Pollastri E, Ricci E, Bonfanti P; STORM Long-COVID Team. A multidisciplinary approach to screen the post-COVID-19 conditions. BMC Infect Dis. 2023 Jan 24;23(1):54. doi: 10.1186\/s12879-023-08006-4. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/36694110\/<\/a><\/li>\n
- Ollila HM, Fonseca-Rodr\u00edguez O, Caspersen IH, Kalucza S, Normark J, Trogstad L, Magnus PM, Rod NH, Ganna A, Eriksson M, Fors Connolly AM. How do clinicians use post-COVID syndrome diagnosis? Analysis of clinical features in a Swedish COVID-19 cohort with 18 months’ follow-up: a national observational cohort and matched cohort study. BMJ Public Health. 2024 Mar 25;2(1):e000336. doi: 10.1136\/bmjph-2023-000336. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/40018228\/<\/a><\/li>\n
- Elnagi EA, Al-Maqati TN, Maawadh RM, AlBahrani S, Al Khalaf FS, Alzahrani FM, Nazzal W, Alanazi M, Abdali AS, Al Atawi AS, Al-Jamea LH, Alshehri AM, ALshammari AA, Suliman RS, Al Bassam I. A Retrospective Study: Evaluating the Impact of the COVID-19 Pandemic on Inflammatory Markers in Hospitalized Patients. Infect Dis Rep. 2024 Aug 14;16(4):735-749. doi: 10.3390\/idr16040056. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11353753\/<\/a><\/li>\n
- Benites-Zapata VA, Ignacio-Cconchoy FL, Ulloque-Badaracco JR, Hernandez-Bustamante EA, Alarc\u00f3n-Braga EA, Al-Kassab-C\u00f3rdova A, Herrera-A\u00f1azco P. Vitamin B12 levels in thyroid disorders: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023 Feb 22;14:1070592. doi: 10.3389\/fendo.2023.1070592. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9994182\/<\/a><\/li>\n
- Sandoval Y, Januzzi JL Jr, Jaffe AS. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 Sep 8;76(10):1244-1258. doi: 10.1016\/j.jacc.2020.06.068. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7833921\/<\/a><\/li>\n
- S NM, G R, Sampath A, Gadwala R, V CG, Pakhare AP, Joshi R, Singhai A, Mishra VN, Khadanga S. The Post-COVID-19 Haul on Pulmonary Function: A Prospective Cross-Sectional Study. Cureus. 2024 May 26;16(5):e61101. doi: 10.7759\/cureus.61101. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/38813071\/<\/a><\/li>\n
- Delgado-Alonso C, D\u00edez-Cirarda M, Pag\u00e1n J, P\u00e9rez-Izquierdo C, Oliver-Mas S, Fern\u00e1ndez-Romero L, Mart\u00ednez-Petit \u00c1, Valles-Salgado M, Gil-Moreno MJ, Yus M, Mat\u00edas-Guiu J, Ayala JL, Matias-Guiu JA. Unraveling brain fog in post-COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms. Eur J Neurol. 2025 Jan;32(1):e16084. doi: 10.1111\/ene.16084. Epub 2023 Oct 5. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/37797297\/<\/a><\/li>\n
- Cantrell C, Reid C, Walker CS, Stallkamp Tidd SJ, Zhang R, Wilson R. Post-COVID postural orthostatic tachycardia syndrome (POTS): a new phenomenon. Front Neurol. 2024 Mar 22;15:1297964. doi: 10.3389\/fneur.2024.1297964. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10998446\/<\/a><\/li>\n
- Torres F, Shedd C, Kaza V, Bollineni S, Banga A, Mohanka MR, Ladikos N, Wijesinha M, Mahan LD, Lawrence A, Joerns J, Terada L, Timofte I. Outpatient management of Post-COVID syndrome – single center experience. Heart Lung. 2024 Sep-Oct;67:137-143. doi: 10.1016\/j.hrtlng.2024.05.004. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/38759575\/<\/a><\/li>\n
- G\u00f3mez-Egu\u00edlaz M, L\u00f3pez-Alava S, Ram\u00f3n-Trapero JL, Castillo-\u00c1lvarez F, G\u00f3mez Loizaga N, Garc\u00eda-Penco C, Boukichou-Abdelkader N, P\u00e9rez-Mart\u00ednez L. Focusing on post-COVID syndrome fatigue. Neurologia (Engl Ed). 2025 Mar;40(2):204-215. doi: 10.1016\/j.nrleng.2025.02.002. Epub 2025 Feb 11. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/39947285\/<\/a><\/li>\n
- S\u00e1nchez-Garc\u00eda JC, Rentero Moreno M, Piqueras-Sola B, Cort\u00e9s-Mart\u00edn J, Li\u00f1\u00e1n-Gonz\u00e1lez A, Mellado-Garc\u00eda E, Rodriguez-Blanque R. Physical Therapies in the Treatment of Post-COVID Syndrome: A Systematic Review. Biomedicines. 2023 Aug 11;11(8):2253. doi: 10.3390\/biomedicines11082253. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10452406\/<\/a><\/li>\n
- Barrea L, Grant WB, Frias-Toral E, Vetrani C, Verde L, de Alteriis G, Docimo A, Savastano S, Colao A, Muscogiuri G. Dietary Recommendations for Post-COVID-19 Syndrome. Nutrients. 2022 Mar 20;14(6):1305. doi: 10.3390\/nu14061305. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/35334962\/<\/a><\/li>\n
- El-Tallawy SN, Perglozzi JV, Ahmed RS, Kaki AM, Nagiub MS, LeQuang JK, Hadarah MM. Pain Management in the Post-COVID Era-An Update: A Narrative Review. Pain Ther. 2023 Apr;12(2):423-448. doi: 10.1007\/s40122-023-00486-1. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9971680\/<\/a><\/li>\n
- Maniscalco M, Ambrosino P, Fuschillo S, Stufano S, Sanduzzi A, Matera MG, Cazzola M. Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation. Respir Med. 2021 Jun;182:106401. doi: 10.1016\/j.rmed.2021.106401. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/33873099\/<\/a><\/li>\n
- Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, Barzegar Z, Kabiri M, Zeraatpisheh Z, Farjoud-Kouhanjani M, Jafari A, Sasannia S, Ashrafi S, Nazeri M, Nasiri S, Shahisavandi M. Long COVID syndrome-associated brain fog. J Med Virol. 2022 Mar;94(3):979-984. doi: 10.1002\/jmv.27404. Epub 2021 Oct 24. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8662118\/<\/a><\/li>\n
- von Falkenhausen AS, Gail A, Geipel S, Scherer C, Stockhausen S, Sams LE, Becker F, Massberg S, K\u00e4\u00e4b S, Sinner MF. Symptoms of Depression and Anxiety After COVID-19 Despite Systematic Telemedical Care: Results From the Prospective COVID-SMART Study. Depress Anxiety. 2025 Apr 13;2025:9989990. doi: 10.1155\/da\/9989990. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12009673\/<\/a><\/li>\n
- Kamilova U, Ermekbaeva A, Nuritdinov N, Khamraev A, Zakirova G. Occurrence of comorbid diseases in patients after COVID-19. J Med Life. 2023 Mar;16(3):447-450. doi: 10.25122\/jml-2022-0168. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10165508\/<\/a><\/li>\n
- Vasiliadis AV, Boka V. Safe Return to Exercise after COVID-19 Infection. Sultan Qaboos Univ Med J. 2021 ;21(3):373-377. doi: 10.18295\/squmj.8.2021.124. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8407897\/<\/a><\/li>\n
- Ling V, Zabetakis I. The Role of an Anti-Inflammatory Diet in Conjunction to COVID-19. Diseases. 2021 Oct 29;9(4):76. doi: 10.3390\/diseases9040076. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8628803\/<\/a><\/li>\n
- Alzueta E, Perrin PB, Yuksel D, Ramos-Usuga D, Kiss O, Iacovides S, de Zambotti M, Cortes M, Olabarrieta-Landa L, Arango-Lasprilla JC, Baker FC. An international study of post-COVID sleep health. Sleep Health. 2022 Dec;8(6):684-690. doi: 10.1016\/j.sleh.2022.06.011. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/36163137\/<\/a><\/li>\n
- Pourfridoni M, Abbasnia SM, Shafaei F, Razaviyan J, Heidari-Soureshjani R. Fluid and Electrolyte Disturbances in COVID-19 and Their Complications. Biomed Res Int. 2021 Apr 14;2021:6667047. doi: 10.1155\/2021\/6667047. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8060100\/<\/a><\/li>\n
- National Institutes of Health, NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million. Available at: https:\/\/www.nih.gov\/about-nih\/who-we-are\/nih-director\/statements\/nih-bolster-recover-long-covid-research-efforts-through-infusion-515-million<\/a><\/li>\n
- Giunta S, Giuliani A, Sabbatinelli J, Olivieri F. A multidimensional immunological perspective on long COVID. Cytokine Growth Factor Rev. 2025 Jul 5:S1359-6101(25)00082-6. doi: 10.1016\/j.cytogfr.2025.07.001. Epub ahead of print. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/40640033\/<\/a><\/li>\n
- Sun G, Lin K, Ai J, Zhang W. The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: a systematic review and meta-analysis. Clin Microbiol Infect. 2024 Dec;30(12):1505-1513. doi: 10.1016\/j.cmi.2024.07.006. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/39002665\/<\/a><\/li>\n
- Yang J, Rai KK, Alfred T, Massey L, Massey O, McGrath L, Andersen KM, Tritton T, Tsang C, Butfield R, Reynard C, Mendes D, Nguyen JL. The impact of COVID vaccination on incidence of long COVID and healthcare resource utilisation in a primary care cohort in England, 2021-2022. BMC Infect Dis. 2025 Feb 13;25(1):214. doi: 10.1186\/s12879-024-10097-6. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/39948466\/<\/a><\/li>\n
- Tsilingiris D, Vallianou NG, Karampela I, Christodoulatos GS, Papavasileiou G, Petropoulou D, Magkos F, Dalamaga M. Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges. Int J Mol Sci. 2023 Jun 21;24(13):10458. doi: 10.3390\/ijms241310458. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/37445634\/<\/a><\/li>\n
- Ahmad I, Amelio A, Merla A, Scozzari F. A survey on the role of artificial intelligence in managing Long COVID. Front Artif Intell. 2024 Jan 11;6:1292466. doi: 10.3389\/frai.2023.1292466. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10808521\/<\/a><\/li>\n<\/ol>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
Evaluare \u0219i tratament sindromul Post-Covid Diagnosticul SPC r\u0103m\u00e2ne o provocare, deoarece nu exist\u0103 un test unic definitiv [1]. Diagnosticul este bazat pe istoricul pacientului de COVID-19 \u0219i persisten\u021ba simptomelor peste 4 s\u0103pt\u0103m\u00e2ni, cu condi\u021bia ca aceste simptome s\u0103 nu poat\u0103 fi explicate prin prezen\u021ba unei alte afec\u021biuni [2]. Evaluarea medical\u0103 include un examen fizic, \u0219i […]<\/p>\n","protected":false},"author":2,"featured_media":1989,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","override":[{"template":"6","parallax":"1","fullscreen":"1","layout":"no-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","share_position":"floatbottom","share_float_style":"share-normal","show_share_counter":"1","show_view_counter":"1","show_featured":"1","show_post_meta":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","post_calculate_word_method":"str_word_count","show_zoom_button":"1","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_popup_post":"1","number_popup_post":"3","show_post_related":"1","show_inline_post_related":"0"}],"image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post_position":"meta","trending_post_label":"Trending","sponsored_post_label":"Sponsored by","disable_ad":"0"},"jnews_primary_category":[],"jnews_override_counter":{"view_counter_number":"0","share_counter_number":"0","like_counter_number":"0","dislike_counter_number":"0"},"footnotes":""},"categories":[9,7],"tags":[],"class_list":["post-1985","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pneumologie","category-orl"],"_links":{"self":[{"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/posts\/1985","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/comments?post=1985"}],"version-history":[{"count":1,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/posts\/1985\/revisions"}],"predecessor-version":[{"id":1990,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/posts\/1985\/revisions\/1990"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/media\/1989"}],"wp:attachment":[{"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/media?parent=1985"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/categories?post=1985"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/roneuro.ro\/blog\/wp-json\/wp\/v2\/tags?post=1985"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
- Emiroglu C, Dicle M, Ozagar SD, Gorpelioglu S, Aypak C. Evaluation of post-acute-COVID-19, and long-COVID symptoms with a questionnaire: Within one year, a longitudinal study. North Clin Istanb. 2024 Apr 22;11(2):105-114. doi: 10.14744\/nci.2023.58908. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/38757107\/<\/a><\/li>\n
- Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol. 2021 Jun 1;72(11):384-396. English, Spanish. doi: 10.33588\/rn.7211.2021230. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/34042167\/<\/a><\/li>\n